AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 188 filers reported holding AXSOME THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 3.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $163,629,124 | -2.9% | 2,341,238 | -0.2% | 19.69% | -17.1% |
Q2 2023 | $168,510,263 | +35.8% | 2,344,980 | +16.6% | 23.76% | +11.3% |
Q1 2023 | $124,078,387 | -20.0% | 2,011,647 | 0.0% | 21.34% | -13.3% |
Q4 2022 | $155,158,333 | +83.3% | 2,011,647 | +6.1% | 24.61% | +65.5% |
Q3 2022 | $84,628,000 | +134.4% | 1,896,647 | +101.2% | 14.88% | +80.1% |
Q2 2022 | $36,100,000 | -7.5% | 942,571 | 0.0% | 8.26% | -10.4% |
Q1 2022 | $39,013,000 | +450.5% | 942,571 | +402.4% | 9.22% | +294.9% |
Q4 2021 | $7,087,000 | +14.6% | 187,598 | 0.0% | 2.34% | +3.9% |
Q3 2021 | $6,183,000 | -70.7% | 187,598 | -40.0% | 2.25% | -74.1% |
Q2 2021 | $21,088,000 | +48.0% | 312,598 | +24.2% | 8.67% | +44.4% |
Q1 2021 | $14,245,000 | -20.6% | 251,598 | +14.3% | 6.00% | -6.4% |
Q4 2020 | $17,931,000 | +14.3% | 220,098 | 0.0% | 6.41% | -3.4% |
Q3 2020 | $15,682,000 | -11.8% | 220,098 | +1.9% | 6.64% | -16.3% |
Q2 2020 | $17,781,000 | +59.4% | 216,098 | +14.0% | 7.93% | +17.2% |
Q1 2020 | $11,154,000 | – | 189,598 | – | 6.76% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |